Supplement sales helped drive gains in Clorox’s lifestyle segment in Q4

By Adi Menayang contact

- Last updated on GMT

iStock / G0d4ather
iStock / G0d4ather

Related tags: Clorox, Collagen, Probiotics

The Clorox Company dived deeper into the supplements space when it bought portfolio company Nutranext earlier this year. How did it affect its Q4 results?

“In our lifestyle segment, Q4 sales increased 21%, reflecting gains from the Nutranext acquisition. And on a full year basis, sales increased 8%, largely reflecting the benefit of Nutranext,”​ reported Lisah Burhan, VP of investor relations for The Clorox Company during its Q4 earnings call this week.

Clorox’s lifestyle segment includes dressings and sauces (Hidden Valley), water filtration (Brita), natural personal care (Burt’s Bees), and dietary supplements, which includes probiotic brand Renew Life and the former Nutranext brands.

It acquired Nutranext in March this year​ for $700 million, which added the brands NeoCell, Rainbow Light, Sedona Labs, and Natural Vitality. The acquisition also diversified Clorox's reach in terms of channels, as some of the brands were direct-to-consumer and online exclusive.

For all segments, Clorox saw its Q4 sales grow by 3%, which, SVP and CFO Kevin Jacobsen attributed to “three points of benefit from Nutranext acquisition” ​during the call.

Gross margin decreased 170 basis points to 44% from 45.7% in last year’s Q4—this included 60 basis points of negative impact from costs related to the Nutranext acquisition.

CEO and chairman Benno Dorer said that he remains confident in the long-term outlook for the company’s health and wellness ventures.

“We continue to anticipate about three points of growth from the newest member of our portfolio, the Nutranext vitamins and dietary supplement business where integration is progressing in line with expectations,”​ he added.

“From a channel perspective, including Nutranext, e-commerce is now estimated at 6% of company sales and we anticipate growing strongly in this channel again in fiscal year 2019 to an estimated 8% of company sales.”

Related news

Show more

Related products

show more

Looking Beyond a Supplement Certificate of Analysis

Looking Beyond a Supplement Certificate of Analysis

Gemini Pharmaceuticals | 25-Feb-2021 | Technical / White Paper

Recently, retailers have been requiring additional assurances that the dietary supplement products they offer for sale meet label claims. Brand Owners...

A Pandemic and Dietary Supplement Label Claims

A Pandemic and Dietary Supplement Label Claims

Gemini Pharmaceuticals | 15-Feb-2021 | Technical / White Paper

As a leading contract manufacturer, Gemini Pharmaceuticals has been helping customers develop unique dietary supplement products for over 38 years. At...

Covid-19: A Game Changer for Probiotics

Covid-19: A Game Changer for Probiotics

Lumina Intelligence | 09-Feb-2021 | Technical / White Paper

This free whitepaper from Lumina Intelligence examines how the pandemic has impacted post-purchase consumer engagement with probiotics, the role of probiotics...

Related suppliers

Follow us

Products

View more

Webinars